MARGINAL ZONE LYMPHOMAS
On behalf of the Journal of Clinical Immunology and Infection Diseases as Editor-in-Chief, it is my distinct honour and privilege to inform you that, it’s been ten long years we have started the Journal, now we are celebrating the 4th Anniversary and we are privileged to welcome Analytical Society to our journal. As Editor-In-Chief it is my great pleasure and honour to welcome you to the Journal of Food Nutrition & Health.
The Journal of Clinical Immunology and Infection Diseases aims to disseminate knowledge and promote discussion through the publication of peer-reviewed, high quality research papers on all topics related to healthy living. The open access journal is published by imedpub International who hosts around 350 open access peer-reviewed journals as well as organizes more than 100 International scientific Conferences.
Marginal zone lymphomas are a group of indolent B-cell lymphomas that arise from memory B cells normally present in a distinct micro-anatomical compartment known as the ‘marginal zone’ of secondary lymphoid tissues. MZL account for approximately 8% of all non-Hodgkin lymphoma cases. The most common MZL entities recognised in the 2017 World Health Organization (WHO) classification of haematological malignancies includes splenic marginal zone lymphoma, nodal marginal zone lymphoma, and extranodal marginal zone lymphoma or mucosa-associated lymphatic tissue lymphoma..
With kind regards,
Journal of Clinical Immunology & Infection Diseases
Tel. No. +3225889658